Key Takeaways
- • Record Q2 2026 venture investment reached $85.7 billion across 166 reported financings, the highest quarterly total since Cooley began tracking data in 2014, driven primarily by a large late-stage technology deal.
- • Series A and Series C rounds increased in deal volume while Series B median pre-money valuations surged 21% quarter-over-quarter (from $152.5 million to $185.2 million), indicating sustained investor appetite at specific growth stages despite overall market unevenness.
- • Up rounds moderated to 83.6% of deals in Q2 from 86.6% in Q1, with down rounds rising to 12.1%, signaling emerging pricing pressure in later-stage rounds where median pre-money valuations fell 75% (Series D and beyond dropped from $2.4 billion to $600 million).
- • Founder-friendly deal terms persisted, with 95.8% of deals maintaining 1x liquidation preferences and 96.4% featuring nonparticipating preferred stock, though pay-to-play provisions increased from 7% to 8.4%, reflecting tightening investor discipline.
- • Exit environment remains a constraint despite improved conditions, with general partners under continued pressure to accelerate distributions and manage portfolio liquidity amid uneven market recovery.
Summary
Venture capital markets reached a historic milestone in Q2 2026, with record quarterly investment of $85.7 billion deployed across 166 reported financings tracked by Cooley, according to the Q2 2026 Venture Financing Report. This represented more than a doubling of invested capital from Q1 2026 and marked the highest quarterly total recorded since the firm began systematic tracking in 2014. The surge was substantially driven by a single large late-stage technology transaction, underscoring the outsized role of mega-deals in current venture dynamics.
Deal activity patterns reveal a bifurcated market with selective momentum. Series A and Series C rounds gained traction in deal count, while Series Seed, Series B, Series D, and later-stage rounds contracted on a volume basis. Series B valuations showed particular strength, with median pre-money valuations climbing 21% to $185.2 million from $152.5 million sequentially. However, this strength did not extend uniformly across the market. Series D and later-stage rounds experienced a dramatic 75% median valuation decline, dropping from $2.4 billion to $600 million, signaling material pricing pressure in late-stage segments. Across all stages, 48% of deals commanded pre-money valuations exceeding $100 million in Q2, up from 41% in Q1, concentrating valuation momentum in higher-bracket rounds.
Pricing discipline tightened measurably in Q2. Up rounds declined to 83.6% of deals from 86.6% in Q1, while down rounds increased to 12.1% from 10.9%, suggesting founders encountered more challenging valuation negotiations. Flat rounds ticked up to 4.3% from 2.5%. These trends indicate a market transitioning from euphoric expansion to more selective, disciplined capital deployment, even as headline investment dollars reach record peaks.
Term sheets remained founder-favorable in structural dimensions. An elevated 95.8% of deals retained 1x liquidation preferences, and 96.4% featured nonparticipating preferred stock, protecting downside economics for entrepreneurs. However, investor protections strengthened incrementally—pay-to-play provisions rose from 7% to 8.4%, and accruing dividends increased from 2.3% to 3%, signaling mounting investor focus on downside mitigation. Redemption provisions declined slightly from 6.4% to 5.4%, a minor concession to founders.
Underlying the record headline figures, the venture market remains in an uneven recovery phase. While H1 2026 achieved record aggregate investment levels via the PitchBook-NVCA Venture Monitor, the exit environment continues constraining general partner liquidity. According to market reports, GPs remain under sustained pressure to accelerate distributions and increase pace of exits, a structural headwind that persists despite improved exit conditions relative to 2025. This dynamic—record dry powder deployment coupled with exit constraints—defines the asymmetric challenge confronting institutional venture investors navigating 2026.
Deal activity patterns reveal a bifurcated market with selective momentum. Series A and Series C rounds gained traction in deal count, while Series Seed, Series B, Series D, and later-stage rounds contracted on a volume basis. Series B valuations showed particular strength, with median pre-money valuations climbing 21% to $185.2 million from $152.5 million sequentially. However, this strength did not extend uniformly across the market. Series D and later-stage rounds experienced a dramatic 75% median valuation decline, dropping from $2.4 billion to $600 million, signaling material pricing pressure in late-stage segments. Across all stages, 48% of deals commanded pre-money valuations exceeding $100 million in Q2, up from 41% in Q1, concentrating valuation momentum in higher-bracket rounds.
Pricing discipline tightened measurably in Q2. Up rounds declined to 83.6% of deals from 86.6% in Q1, while down rounds increased to 12.1% from 10.9%, suggesting founders encountered more challenging valuation negotiations. Flat rounds ticked up to 4.3% from 2.5%. These trends indicate a market transitioning from euphoric expansion to more selective, disciplined capital deployment, even as headline investment dollars reach record peaks.
Term sheets remained founder-favorable in structural dimensions. An elevated 95.8% of deals retained 1x liquidation preferences, and 96.4% featured nonparticipating preferred stock, protecting downside economics for entrepreneurs. However, investor protections strengthened incrementally—pay-to-play provisions rose from 7% to 8.4%, and accruing dividends increased from 2.3% to 3%, signaling mounting investor focus on downside mitigation. Redemption provisions declined slightly from 6.4% to 5.4%, a minor concession to founders.
Underlying the record headline figures, the venture market remains in an uneven recovery phase. While H1 2026 achieved record aggregate investment levels via the PitchBook-NVCA Venture Monitor, the exit environment continues constraining general partner liquidity. According to market reports, GPs remain under sustained pressure to accelerate distributions and increase pace of exits, a structural headwind that persists despite improved exit conditions relative to 2025. This dynamic—record dry powder deployment coupled with exit constraints—defines the asymmetric challenge confronting institutional venture investors navigating 2026.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.